Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease
NCT05688852 is registered in ClinicalTrials.gov with Ventyx Biosciences, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease
- Lead sponsor
- Ventyx Biosciences, Inc
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 25, 2023
- Completion date
- December 20, 2024
- Enrollment
- 107 (actual)
- Sites
- 105
Conditions
As the registry lists them; a condition with its own page is linked.